| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0003 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |